IPIX
Innovation Pharmaceuticals Inc.
Set alert
0.00 USD 0.00 0.00%
0.0007 Day range 0.012
0.0001 52-week range 0.003
- YTD
- -80.00%
- 1 year
- -80.00%
- Open
- 0.012
- Prev close
- 0.0002
- Mkt cap
- 103.67K
- Vol
- 12.60K
- Avg vol
- 313.39K
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.0007
- High
- 0.012
News
- Innovation X Advisors Participates in Shield AI's $1.5 Billion Series G Financing
- AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts
- INVNT™ Announced as Sponsor and Co-Producer of Discovery Stage at SXSW Sydney® 2024
- Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024
- Innovation Pharma Announces New Brilacidin Antiviral Research on Non-SARS-CoV-2 Endemic Viral Diseases to be Presented at the 2021 Military Health System Research Symposium
- Patient Enrollment Reaches 90 Percent in Innovation Pharmaceuticals Phase 2 Clinical Trial of Brilacidin for COVID-19
- Innovation Pharma Surpasses 50 Percent Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19
- Innovation Pharma's Broad Spectrum Antiviral Drug Candidate Brilacidin Highlighted in Biodefense and Infectious Diseases COVID-19 Presentation
- Innovation Pharma Announces Brilacidin Abstract Accepted for Oral Presentation at the American Society for Virology's Annual Meeting
- Innovation Pharma Completes Interim Safety Data Review—DMC Approves Increased Dosing Frequency in Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients
Your note
Sign in to keep a note on IPIX — it syncs with the Stock Master app.